Literature DB >> 8252685

Platelet activation during coronary angioplasty in humans.

C M Gasperetti1, S L Gonias, L W Gimple, E R Powers.   

Abstract

BACKGROUND: Previous studies have indicated that balloon angioplasty is associated with local platelet activation. In addition, different contrast media have different effects on thrombus formation during angioplasty in humans. We hypothesized that coronary angioplasty in humans is associated with activation of platelets to specific platelet agonists and that this activation may be differently modified by different angiographic contrast agents. METHODS AND
RESULTS: We studied 25 patients referred for angioplasty of the left anterior descending or circumflex coronary arteries. All patients were pretreated with aspirin and received heparin. Blood samples for assessment of platelet aggregation to serotonin, ADP, epinephrine, and collagen were obtained from the coronary sinus before any contrast injection, after initial diagnostic contrast injections, and after three balloon inflations. Patients were randomized to receive iopamidol, diatrizoate, or ioxaglate. Contrast alone was not associated with altered platelet aggregation. However, balloon angioplasty was consistently associated with increased platelet aggregation to serotonin but not to ADP, epinephrine, or collagen. These effects were similar with the three contrast agents studied except that the use of iopamidol was associated with increased platelet responsiveness to all concentrations of ADP after balloon dilation.
CONCLUSIONS: Coronary angioplasty in humans was associated with increased platelet aggregation in blood drawn from the coronary sinus. This effect was primarily seen when serotonin was used as an agonist.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252685     DOI: 10.1161/01.cir.88.6.2728

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

Review 1.  Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.

Authors:  F H Jafary; C D Kimmelstiel
Journal:  J Thromb Thrombolysis       Date:  2000-02       Impact factor: 2.300

2.  Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.

Authors:  H Dai; J Chen; Q Tao; J Zhu; F Zhang; L Zheng; Y Qiu
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

3.  Regional and Systemic Platelet Function Is Altered by Myocardial Ischemia-Reperfusion.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

4.  Changes in serum serotonin levels in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention.

Authors:  Donghoon Han; Jae Hyuk Choi; Sehun Kim; Sang Min Park; Dong Geum Shin; Min-Kyung Kang; Seonghoon Choi; Namho Lee; Jung Rae Cho
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

5.  LDL-C and Total Stent Length are Independent Predictors of Periprocedural Myocardial Injury and Infarction for Unstable Angina Patients Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Xuefeng Chen; Chunli Rong; Peng Qi; Wenlou Bai; Wenjing Yao; Yantao Zhang; Yi Dang
Journal:  Int J Gen Med       Date:  2021-04-16

6.  Independent predictors of acute kidney injury in patients with acute coronary syndrome after percutaneous coronary intervention.

Authors:  Aisulu Zhunuspekova; Jamilya Mansurova; Lyudmila Karazhanova
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

7.  The role of monocyte phenotype switching in peri-procedural myocardial injury and its involvement in statin therapy.

Authors:  Yang Yang; Yi Cui; Dao-Quan Peng
Journal:  Med Sci Monit       Date:  2013-11-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.